Chmp

2 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business 🔮 fades

European regulators are recommending the revocation of marketing authorization for Amgen's rare-disease drug Tavneos following new data.

6 sources 6 articles v 4 2h ago

↑ Rising Business 🔮 holds

Eli Lilly shares surge following the CHMP's recommendation for the approval of Jaypirca in the European Union.

11 sources 12 articles v 10 2h ago